PT3004076T - Novos compostos de 3,4-di-hidro-2h-isoquinolina-1-ona e de 2,3-di-hidro-isoindol-1-ona - Google Patents

Novos compostos de 3,4-di-hidro-2h-isoquinolina-1-ona e de 2,3-di-hidro-isoindol-1-ona

Info

Publication number
PT3004076T
PT3004076T PT147263636T PT14726363T PT3004076T PT 3004076 T PT3004076 T PT 3004076T PT 147263636 T PT147263636 T PT 147263636T PT 14726363 T PT14726363 T PT 14726363T PT 3004076 T PT3004076 T PT 3004076T
Authority
PT
Portugal
Prior art keywords
dihydro
isoindol
isoquinoline
compounds
new
Prior art date
Application number
PT147263636T
Other languages
English (en)
Inventor
Aebi Johannes
Amrein Kurt
Chen Wenming
Hornsperger Benoit
Kuhn Bernd
Liu Yongfu
P Maerki Hans
E Martin Rainer
V Mayweg Alexander
Tan Xuefei
Wang Lisha
Zhou Mingwei
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT3004076T publication Critical patent/PT3004076T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT147263636T 2013-05-27 2014-05-26 Novos compostos de 3,4-di-hidro-2h-isoquinolina-1-ona e de 2,3-di-hidro-isoindol-1-ona PT3004076T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013076285 2013-05-27

Publications (1)

Publication Number Publication Date
PT3004076T true PT3004076T (pt) 2019-12-18

Family

ID=50819739

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147263636T PT3004076T (pt) 2013-05-27 2014-05-26 Novos compostos de 3,4-di-hidro-2h-isoquinolina-1-ona e de 2,3-di-hidro-isoindol-1-ona

Country Status (20)

Country Link
US (1) US9695152B2 (pt)
EP (1) EP3004076B1 (pt)
JP (2) JP6416230B2 (pt)
AR (1) AR096425A1 (pt)
BR (1) BR112015029691B1 (pt)
CA (1) CA2902848C (pt)
DK (1) DK3004076T3 (pt)
ES (1) ES2763424T3 (pt)
HK (1) HK1213556A1 (pt)
HR (1) HRP20192242T1 (pt)
HU (1) HUE046739T2 (pt)
LT (1) LT3004076T (pt)
MX (1) MX368759B (pt)
PL (1) PL3004076T3 (pt)
PT (1) PT3004076T (pt)
RS (1) RS59663B1 (pt)
RU (1) RU2693698C2 (pt)
SI (1) SI3004076T1 (pt)
TW (1) TWI704143B (pt)
WO (1) WO2014191340A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102436885B1 (ko) * 2013-05-27 2022-08-26 에프. 호프만-라 로슈 아게 신규한 3,4-다이하이드로-2h-이소퀴놀린-1-온 및 2,3-다이하이드로-이소인돌-1-온 화합물
UA122061C2 (uk) * 2014-10-08 2020-09-10 Ф. Хоффманн-Ля Рош Аг Похідні спіродіаміну як інгібітори альдостеронсинтази
WO2019126559A1 (en) 2017-12-20 2019-06-27 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482951B2 (en) * 2000-12-13 2002-11-19 Hoffmann-La Roche Inc. Isoindolin-1-one glucokinase activators
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
EP2627648A1 (en) * 2010-09-16 2013-08-21 Novartis AG 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
EA035757B1 (ru) * 2011-09-15 2020-08-05 Ф.Хоффманн-Ля Рош Аг Производные дигидрохинолин-2-она
US9353081B2 (en) * 2011-09-23 2016-05-31 Hoffmann-La Roche Inc. Bicyclic dihydroquinoline-2-one derivatives

Also Published As

Publication number Publication date
TW201534596A (zh) 2015-09-16
JP2016520106A (ja) 2016-07-11
ES2763424T3 (es) 2020-05-28
AR096425A1 (es) 2015-12-30
SI3004076T1 (sl) 2020-02-28
EP3004076B1 (en) 2019-10-23
JP2019014738A (ja) 2019-01-31
BR112015029691A2 (pt) 2017-07-25
RS59663B1 (sr) 2020-01-31
MX368759B (es) 2019-10-15
PL3004076T3 (pl) 2020-04-30
RU2015149956A3 (pt) 2018-03-19
WO2014191340A1 (en) 2014-12-04
US20160075688A1 (en) 2016-03-17
JP6416230B2 (ja) 2018-10-31
HRP20192242T1 (hr) 2020-03-06
RU2693698C2 (ru) 2019-07-04
CA2902848A1 (en) 2014-12-04
LT3004076T (lt) 2020-01-10
CA2902848C (en) 2021-09-21
HUE046739T2 (hu) 2020-03-30
BR112015029691B1 (pt) 2023-03-28
TWI704143B (zh) 2020-09-11
EP3004076A1 (en) 2016-04-13
RU2015149956A (ru) 2017-07-04
US9695152B2 (en) 2017-07-04
HK1213556A1 (zh) 2016-07-08
MX2015015058A (es) 2016-02-11
DK3004076T3 (da) 2020-01-02

Similar Documents

Publication Publication Date Title
IL240126A0 (en) (5, 3-Dimethylisoxazol-4-yl)indoline-2-ones that are converted at position 5
HK1214258A1 (zh) 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物
HK1213564A1 (zh) 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物
GB201302863D0 (en) The Instaponytail
HK1213556A1 (zh) 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
GB201312513D0 (en) 2 4 1 Technology
ZA201508354B (en) Substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
GB201322568D0 (en) Taggstar 1
GB201310407D0 (en) Plantladders 3
GB201310285D0 (en) Twist-Away 270
GB201320739D0 (en) The fold-a-way
GB201319475D0 (en) The wiperactive
GB201317585D0 (en) The dehydrometer
GB201316470D0 (en) The walkersize
GB201316056D0 (en) The hoddylock
GB201301398D0 (en) Betterbidet new Jan 26th 2013
GB201315586D0 (en) The adulation
GB201314047D0 (en) The Homeheater
GB201306173D0 (en) The Dehydrometer
GB201305912D0 (en) The barlaston wassail
GB201311503D0 (en) Concept 38
GB201311491D0 (en) Concept 54
GB201311501D0 (en) Concept 37
GB201311488D0 (en) Concept 51